According to our new research study on “Health Economics and Outcomes Research (HEOR) Services Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Service, Service Provider, and End User,” the market is expected to reach US$ 2,699.56 million by 2027 from US$ 1,116.38 million in 2019; it is estimated to grow at a CAGR of 11.9% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the overall healthcare economics and outcomes research (HEOR) services market is attributed to increasing product development and growing healthcare spending. However, restrictions on access to real-world data (RWD) is the major factor hindering the market growth.
Health economics and outcomes research (HEOR) services play a significant role in drug approval and reimbursement with payers. The HEOR services allow to evaluate the economics of treatment and quantify the associated results. Likewise, in the healthcare industry, decision-makers experience the pressure to opt for therapeutic ‘interventions’ from various treatment options made available by pharmaceuticals, medical devices, and biotechnology companies. The growth of the overall healthcare economics and outcomes research (HEOR) services market is attributed to the increasing product development and growing healthcare spending. However, restrictions on access to real-world data (RWD) is the major factor hindering the market growth.
Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017816/
Axtria, Inc.; Avalon Health Economics LLC; MEDLIOR; PHARMALEX GMBH; Analysis Group; ICON PLC; IQVIA Inc.; McKESSON CORPORATION; Syneos Health; and Optum, Inc. are among the leading companies operating in the healthcare economics and outcomes research (HEOR) services market.
Based on service, the healthcare economics and outcomes research (HEOR) services market is segmented into economic modelling/evaluation, real-world data analysis and information systems, clinical outcome, and market access solutions and reimbursement. The clinical outcome segment held the largest market share in 2019, and the real-world data analysis and information systems segment is estimated to register the highest CAGR during the forecast period. Rising number of clinical trials and growing pharmaceutical research and development activities offer lucrative opportunities for the growth of the real-world data analysis segment.
The healthcare economics and outcomes research (HEOR) services market is expected to witness substantial growth post-pandemic. The global healthcare infrastructure observed limitations and capabilities during the sudden emergence of coronavirus. In order to deal with such situations in years to come, healthcare organizations as well as governments are expected to increase the utilization of HEOR services, which would eventually drive the market. Moreover, increase in demand for advanced data analysis technologies is anticipated to drive the market.
However, this spending can be saved by properly managing the money to avoid more spending on the ‘waste domains,’ such as failure of care, improper coordination, overtreatment or low-value care, pricing failure, fraud and abuse, and several administrative complexities. Organisation for Economic Co-operation and Development (OECD) is trying to figure out the minimum wastage of healthcare spending. According to an OECD report for 2017, “A significant share of health spending in OECD countries is at best ineffective and at worst, wasteful.” One-fifth of the total health spending can be properly channelized for efficient use. More than 9% of GDP is spent across the OECD countries, among which three quarters are paid for by governments. Such waste weakens the financial sustainability of health systems. Hence, financial sustainability requires proper management, and the money can be used by appropriate diagnosis and treatment planning to reduce the cost of healthcare services.
The report segments healthcare economics and outcomes research (HEOR) services market as follows:
- Economic Modelling/Evaluation
- Real-World Data Analysis and Information Systems
- Clinical Outcome
- Market Access Solutions and Reimbursement
By Service Provider
- Contract Research Organization
By End User
- Healthcare Providers
- Healthcare Payers
- Biotech/Pharma Companies
- Government Organizations
Health Economics and Outcomes Research (HEOR) Services Market – by Geography
- North America
- Rest of Europe
- Asia Pacific (APAC)
- South Korea
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
- South America and Central America (SCAM)
- Rest of SCAM
Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00017816/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Company Name: The Insight Partners
Contact Person: Sameer Joshi
Email: Send Email